Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Neptune Technologies & Bioressources Inc.
Type
Public
Traded as TSX: NTB
NASDAQ: NEPT
Industry Biotechnology, Life Sciences
Founded October 9, 1998
Headquarters Laval, Quebec, Canada
Area served
Over 30 Countries Worldwide
Key people
Jim Hamilton, President, CEO
Number of employees
Est. 100 (2012)
Subsidiaries Acasti Pharma
Website www.neptunebiotech.com
www.neptunekrilloil.com

Neptune Technologies & Bioressources Inc. is a life sciences company based in Laval, Quebec. The primary operations of the company are the research and development of value added natural products and the manufacturing of Neptune Krill Oil (NKO).

Investment goal date:
Dividends reinvested
Neptune Technologies & Bioressources Inc. NEPT report Q1 2017
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q3 2017
2018-02-14
--
--
Q2 2017
2017-11-13
--
--
Q1 2017
2017-08-14
-0.0200
-0.0200
Q3 2016
2017-01-12
-0.0300
0.1400
Q2 2016
2016-10-12
-0.0200
-0.0200
Q1 2016
2016-07-11
0.0000
-0.0300
Q4 2015
2016-05-25
0.0100
0.0100
Q3 2015
2016-01-12
-0.0300
-0.0200
Q2 2015
2015-10-14
-0.0300
-0.0200
Q1 2015
2015-07-13
-0.0600
-0.0600
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
MORGAN STANLEY
7427
WYNNEFIELD CAPITAL INC
1825450
Major Shareholders
Name Relationship
Total Shares
Holding stocks